
==== Front
Cureus
Cureus
2168-8184
Cureus
2168-8184
Cureus Palo Alto (CA)

10.7759/cureus.67021
Obstetrics/Gynecology
Comparative Study of Pregnancy Outcomes in Women With COVID-19 Disease During the Three Waves of the Pandemic in Eastern India
Muacevic Alexander
Adler John R
Choudhary Anisha 1
Barik Archana 1
Singh Vinita 1
Gorwadkar Abhijeet S 1
Datta Mamta R 1
Ray Alokananda 1
Ghosh Mousumi D 1
1 Obstetrics and Gynecology, Tata Main Hospital, Jamshedpur, IND
Anisha Choudhary dr.anishachoudhary@gmail.com
16 8 2024
8 2024
16 8 e6702116 8 2024
Copyright © 2024, Choudhary et al.
2024
Choudhary et al.
https://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License CC-BY 4.0., which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
This article is available from https://www.cureus.com/articles/267950-comparative-study-of-pregnancy-outcomes-in-women-with-covid-19-disease-during-the-three-waves-of-the-pandemic-in-eastern-india
Introduction

Healthcare systems around the world were disrupted by the COVID-19 pandemic. Multiple waves were experienced by most countries, and clinical symptoms and severity varied between these waves. A COVID-19 infection in pregnant women may result in complications for both the mother and the fetus and thus pose an additional challenge for clinicians. The study of the different presentations, complications, and pregnancy outcomes during the three waves is important to study the effect of the disease on pregnant women.

Objective

This study aimed to analyze and compare the clinical presentations, comorbid conditions, complications, and pregnancy outcomes in women with SARS-CoV-2 infection during the three waves of the pandemic.

Methodology

The present study is a comparative study undertaken at Tata Main Hospital, a referral hospital in Jamshedpur in eastern India. The study period was from May 2020 to February 2022 and was divided according to the three waves of the pandemic. The duration of the first wave was between 1st May 2020 and 28th February 2021; the second wave was between 1st March 2021 and 31st October 2021; and the third wave was between 1st November 2021 and 28th February 2022. A total of 306 pregnant women tested positive for COVID-19 disease during the study period. A retrospective collection of data was done, and clinical findings, laboratory results, comorbid conditions, and outcomes were compared across the three waves.

Results

During the first wave of the pandemic, 139 COVID-19-positive pregnant women were admitted to our hospital. During the second wave, 110 admitted pregnant women tested positive for SARS-CoV-2 infection, and during the third wave, 57 pregnant women tested positive for SARS-CoV-2 infection. Asymptomatic or mild disease was the most commonly seen presentation during all the waves, but a significantly higher number of moderate and severe cases were seen during the second wave. The second wave also witnessed a higher rate of cesarean sections when compared to the other two waves. The preterm delivery rate was 27.8%, 24.7%, and 25% during the first, second, and third waves of the pandemic, respectively. The third wave of the pandemic had the highest percentage of stillbirths, which was significantly higher than both the first and second waves. The COVID-19 test was positive in four babies during the study period.

Conclusion

The severity of COVID-19 disease varied among the three waves, and the second wave recorded the maximum number of moderate and severe cases. Maternal mortality was also significantly higher during the second wave. The rate of preterm deliveries was high during all the waves, and the incidence of stillbirths was highest during the third wave.

third wave
second wave
first wave
preterm
maternal outcome
pregnancy
pandemic
covid-19
==== Body
pmcIntroduction

The initial cases of the coronavirus infection occurred in Wuhan, China, in December 2019 and January 2020 [1], and thereafter it spread rapidly across the globe. The World Health Organization (WHO) declared COVID-19 a pandemic on March 11, 2020 [2]. The first case of COVID-19 in India was reported on January 30, 2020, in Kerala [3], after which India entered the first wave of the pandemic. The second wave of the pandemic began in March 2021 and was much more severe and devastating than the first, with a shortage of healthcare facilities and medical supplies throughout the country. The Omicron-dominant third wave began in January 2022 with high infectivity but low severity of the disease [4].

At the beginning of the pandemic, very little was known about the effect of COVID-19 disease on pregnancy. It was expected that pregnant women would suffer from more severe symptoms, as was experienced earlier in pregnant women with severe acute respiratory syndrome (SARS) and Middle East respiratory syndrome (MERS) infections [5,6]. The initial evidence during the first wave reported that pregnant women with SARS-CoV-2 infection did not suffer from more severe disease as compared to non-pregnant women of the same age group [7]. However, as the pandemic continued, findings from a large systemic review and meta-analysis of global data suggested that COVID-19 disease in pregnancy is associated with a higher incidence of severe infection, need for ventilation, and mortality [8]. Several studies have also concluded that the severity of the disease was significantly higher during the second wave as compared to the first wave [9-11]. Mahajan et al. conducted a study in Mumbai, India, and concluded that pregnant women with COVID-19 disease were more severely affected during the first and second waves when compared to the third wave [12].

There is a paucity of research on the effect of COVID-19 disease on pregnancy, especially in eastern India. In this study, we present a comparative analysis of disease presentation, comorbidities, severity, and pregnancy outcomes in women affected by COVID-19 through the three waves of the pandemic.

Materials and methods

The present study is a retrospective observational study of the pregnancy outcomes of women with SARS-CoV-2 infection admitted to the COVID-19 wing at Tata Main Hospital, a referral hospital in Jamshedpur in eastern India, from May 2020 to February 2022. The study period was divided into three according to the occurrence of the different waves of the pandemic. The duration of the first wave was between 1st May 2020 and 28th February 2021; the second wave was between 1st March 2021 and 31st October 2021; and the third wave was between 1st November 2021 and 28th February 2022.

In accordance with national testing guidelines, all pregnant women visiting the hospital were tested for SARS-CoV-2 infection [13] and categorized into mild, moderate, and severe COVID-19 disease [14]. A total of 306 pregnant women tested positive for SARS-CoV-2 during the study period, and data about their clinical presentation, laboratory findings, management, complications, and pregnancy outcome was retrospectively entered in a Microsoft Excel sheet (Microsoft Corp., Redmond, WA). The data were expressed as frequency (percentage) or median and standard deviation. Comparative analysis of different waves was done by using the Mann-Whitney U test for continuous variables and Pearson’s chi-square test or Fisher's exact test for categorical variables. The confidence interval was 95%, and a p-value <0.05 was considered statistically significant.

Results

During the study period, 306 pregnant women tested positive for COVID-19 infection. The first wave of the pandemic was considered between 1st May 2020 and 28th February 2021, during which 139 COVID-19-positive pregnant women were admitted to our hospital. During the second wave (1st March 2021 to 31st October 2021), 110 admitted pregnant women tested positive for the SARS-CoV-2 infection, and during the third wave (1st November 2021 to 28th February 2022), 57 pregnant women tested positive for the SARS-CoV-2 infection. As shown in Figure 1, the first wave lasted the longest and peaked during the months of August 2020 to October 2020. This was followed by a sudden, sharp rise in the number of cases during the months of April and May 2021, marking the second wave of the pandemic. The number of moderate and severe cases was also significantly higher in the second wave when compared to the first and third waves. The Omicron virus-dominant third wave was the shortest, with no moderate or severe cases.

Figure 1 Timelines of the first, second, and third waves of the pandemic

The red dashed lines divide the timeline into the three pandemic waves.

The mean age of the study group was 27.45±4.51 years, 28.45±4.45 years, and 28.45±4.81 years during the first, second, and third waves, respectively. Pregnant women during the second wave were admitted at a lower period of gestation when compared to those during the first wave (Table 1).

Table 1 Demographic profile of pregnant women with COVID-19 infection during the three waves of the pandemic

SD: standard deviation

*Significant at p-value <0.05

Parameter	First wave	Second wave	Third wave	p-value	
Mean (SD)	Mean (SD)	Mean (SD)	First wave vs. second wave	First wave vs. third wave	Second wave vs. third wave	
Age (years)	27.45 (4.51)	28.45 (4.45)	28.45 (4.81)	0.100	0.07	0.102	
Period of gestation (weeks)	35.83 (6.23)	33.70 (8.10)	35.30 (7.38)	0.037*	0.945	0.163	

Most of the women with COVID-19 infection during pregnancy remained asymptomatic or had mild symptoms during all the waves of the pandemic. The second wave was more severe than the other two waves and also witnessed four cases of maternal mortality (Table 2).

Table 2 Disease severity among pregnant women with SARS-CoV-2 infection during the three waves of the pandemic

*Significant at p-value <0.05

Severity	First wave n (%)	Second wave n (%)	Third wave n (%)	p-value	
First wave vs. second wave	First wave vs. third wave	Second wave vs. third wave	
Asymptomatic	52 (37.4)	43 (39.1)	47 (82.5)	0.013*  	<0.0001*  	<0.0001*  	
Mild	83 (59.7)	53 (48.2)	10 (17.5)	
Moderate	2 (1.4)	10 (9.1)	0 (0.0)	
Severe	2 (1.4)	4 (3.6)	0 (0.0)	
Mortality	0 (0.0)	4 (3.6)	0 (0.0)	0.037*	>0.9999	0.030*	

Hypertensive disorders (preeclampsia, gestational hypertension, and chronic hypertension) and diabetes (gestational diabetes and type 2 diabetes mellitus) were the most frequently associated comorbidities among pregnant women. Deranged liver enzymes were seen in more than 50% of study subjects during the second wave, which was significantly more than that observed during the first and third waves (Table 3).

Table 3 Comorbidities seen among women with COVID-19 infection during pregnancy

*Significant at p-value <0.05

DM: diabetes mellitus; GDM: gestational diabetes mellitus; HTN: hypertension; GHTN: gestational hypertension

Comorbidities	First wave n (%)	Second wave n (%)	Third wave n (%)	p-value	
First wave vs. second wave	First wave vs. third wave	Second wave vs. third wave	
DM/GDM	17 (12.23)	16 (14.55)	7 (1.23)	0.593	0.770	0.790	
Anemia	12 (8.63)	11 (10)	3 (5.3)	0.711	0.560	0.339	
Cardiovascular disease	0 (0.00)	2 (1.82)	0 (0.00)	0.194	>0.99	0.19	
HTN/GHTN	18 (12.94)	16 (14.55)	9 (15.8)	0.612	0.87	0.70	
Deranged liver enzymes	54 (38.85)	57 (51.82)	21 (36.84)	<0.0001*	0.099	<0.0001*	
Morbid obesity	2 (1.44)	2 (1.82)	1 (1.75)	0.816	0.723	0.812	

As seen in Table 4, the cesarean section rate was significantly higher during the second wave (78.8%) when compared to the first (64.6%) and the third wave (52.1%). Two patients during the second wave and one each during the first and third waves had laparotomies for ruptured ectopic pregnancies. The preterm delivery rate was 27.8%, 24.7%, and 25% during the first, second, and third waves of the pandemic, respectively, and this difference did not reach statistical significance. The third wave of the pandemic had the highest percentage of stillbirths (8.3%), which was significantly higher than both the first and second waves. Four babies tested positive for COVID-19 infection after birth, two of them during the second wave and one each during the other two waves.

Table 4 Comparative analysis of mode of delivery and neonatal outcomes of COVID-19 disease in pregnant women during the first, second, and third waves of COVID-19

*Significant at p-value <0.05

Parameter	First wave n (%)	Second wave n (%)	Third wave n (%)	p-value	
First wave vs. second wave	First wave vs. third wave	Second wave vs. third wave	
Mode of delivery	
Cesarean section	82 (64.6)	67 (78.8)	25 (52.1)	0.032*	0.138	0.014*	
Vaginal delivery	45(35.4)	18 (21.2)	23 (47.9)	
Ectopic pregnancy	1 (0.7)	2 (1.8)	1 (1.8)	0.12	0.12	0.88	
Neonatal outcome	
Preterm	35 (27.8)	21 (24.7)	11 (25.0)	0.620	0.730	0.72	
Low birth weight	36 (29.3)	26 (31.0)	14 (31.8)	0.795	0.810	0.910	
Still birth	4 (2.9)	2 (1.9)	4 (8.3)	0.699	0.06	0.03*	
Neonatal death	3 (2.4)	1 (1.2)	0 (0.0)	0.648	0.058	0.781	
COVID-19-positive	2 (1.6)	1 (1.2)	1 (2.3)	0.794	0.541	0.991	

Discussion

The COVID-19 pandemic presented multiple challenges to the healthcare system globally. A three-wave pattern of coronavirus infection was seen in most countries during the pandemic. Differences in the severity of the disease have been reported during the three waves; however, data on comparative analysis of the pregnancy outcomes in women with SARS-CoV-2 infection during the three waves are scarce.

The peak of the first wave was seen during the second half of 2020, and the number of cases started to decrease thereafter. The second wave of COVID-19 began in late March 2021 and was more virulent and severe than the first [15]. In November 2021, another heavily mutated B1.1.1.529 variant, also called Omicron, was reported as concerning and responsible for the third wave of the pandemic in our country [16]. In our study, 139 pregnant women tested positive for SARS-CoV-2 infection during the first wave (May 2020 to February 2021). During the second wave (March 2021 to October 2021), 110 admitted pregnant women tested positive for SARS-CoV-2 infection, and during the third wave (November 2021 to February 2022), 57 pregnant women tested positive for SARS-CoV-2 infection. The number of admissions was higher during the first wave when compared to the second and third, but most of these women during the first wave (97%) were asymptomatic or had mild symptoms. The second wave of the COVID-19 pandemic was the most severe among the three waves and witnessed four maternal mortalities. Ambedkar et al. did a comparative analysis of pregnancy outcomes among women with COVID-19 disease during the first and second waves of the pandemic. They reported a higher number of admissions among pregnant women in the first wave when compared to the second wave [17]. Mahajan et al. conducted a study in Mumbai and reported decreased severity, admission to the intensive care unit, case fatality rate, and maternal mortality ratio during the third wave of the pandemic [12]. A higher incidence of severe illness among pregnant women was also recorded in the United Kingdom during the second wave [18].

In our study, the mean age of the study subjects did not statistically differ during the three waves. The most frequently associated comorbidities seen in our study were hypertensive disorders and diabetes. Singh et al. conducted a study in Jaipur, India, and reported that the pregnant women admitted during the second wave were younger, and those admitted during the third wave had significantly more comorbid conditions [15]. Approximately half of the pregnant women with COVID-19 infection had altered liver enzymes during the second wave of the pandemic, which was significantly more than that observed during the first and third waves. Several studies have reported an association between COVID-19 infection and acute liver dysfunction. Drug interactions, septic shock, acute respiratory failure, and multiorgan dysfunction have been described as the causative factors for liver injury in COVID-19-positive patients [19,20]. The extent of liver dysfunction has also been significantly associated with elevated inflammatory markers, prolonged hospital length of stay, and a more severe clinical course [19,21].

In our study, a significantly higher percentage of pregnant women had a cesarean section when compared to the other two waves. Various studies across the globe have reported a high cesarean section rate among pregnant women infected with SARS-CoV-2 [10,18]. Silva et al. reported that this increase is mainly due to maternal requests and fear concerning the outcome of the disease [22]. The preterm birth rate remained high during all three waves (27.8%, 24.7%, and 25% during the three waves, respectively). Many studies have reported that COVID-19 infection in pregnant women raises the risk of preterm birth, but the data are still conflicted on whether these are iatrogenic or spontaneous preterm deliveries [10,23,24]

Neonatal COVID-19 infection was documented in two babies during the first wave, one during the second wave, and one during the third wave, respectively. All four babies did not develop any symptoms and were roomed in along with their mothers. Chaudhary et al. reported neonatal COVID-19 infection in five babies during their study period [10]. There were few initial reports against the possibility of vertical transmission of the SARS-CoV-2 infection [25]. However, recent literature shows that vertical transmission of SARS-CoV-2 is possible and seems to occur in a minority of cases [26].

The limitations of the study include that it is a single-center study with a comparatively small sample size. We could not assess the different SARS-CoV-2 variants during the three waves of the pandemic due to the non-availability of genome sequencing. We also lack follow-up to assess the long-term sequelae of the disease on the mother and the neonate.

Conclusions

Our study concludes that the COVID-19 infection in pregnancy may present with varied symptoms, complications, and severity. The first wave lasted longer than the other two waves; however, the majority of patients remained asymptomatic during the first wave. The second wave was the most severe, and the third wave was the mildest. This variation may be because of the nationwide vaccination drive or the new mutated strain of the virus. All three waves witnessed a high rate of preterm deliveries, and neonatal COVID-19 infection was documented in four babies during the study period, concluding that vertical transmission of COVID-19 infection is a possibility. Further research should be directed toward understanding the course and outcome of the disease among pregnant women. This will help us overcome the unpredictable nature of mutations, and the healthcare sector will be better equipped to handle such types of infections in the future.

Disclosures

Author Contributions

Human subjects: Consent was obtained or waived by all participants in this study.

Animal subjects: All authors have confirmed that this study did not involve animal subjects or tissue.

Conflicts of interest: In compliance with the ICMJE uniform disclosure form, all authors declare the following:

Payment/services info: All authors have declared that no financial support was received from any organization for the submitted work.

Financial relationships: All authors have declared that they have no financial relationships at present or within the previous three years with any organizations that might have an interest in the submitted work.

Other relationships: All authors have declared that there are no other relationships or activities that could appear to have influenced the submitted work.

Concept and design:  Anisha Choudhary, Archana Barik, Vinita Singh, Abhijeet S. Gorwadkar, Mamta R. Datta, Alokananda Ray, Mousumi D. Ghosh

Acquisition, analysis, or interpretation of data:  Anisha Choudhary, Archana Barik, Vinita Singh, Abhijeet S. Gorwadkar

Drafting of the manuscript:  Anisha Choudhary, Archana Barik, Vinita Singh, Abhijeet S. Gorwadkar

Critical review of the manuscript for important intellectual content:  Anisha Choudhary, Mamta R. Datta, Alokananda Ray, Mousumi D. Ghosh
==== Refs
References

1 Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia N Engl J Med Li Q Guan X Wu P 1199 1207 382 2020 31995857
2 Third wave of the COVID-19 pandemic: prominence of initial public health interference Infect Disord Drug Targets Mukherjee S Ray SK 0 22 2022
3 First confirmed case of COVID-19 infection in India: a case report Indian J Med Res Andrews MA Areekal B Rajesh KR 490 492 151 2020 32611918
4 Omicron variant of SARS-CoV-2: genomics, transmissibility, and responses to current COVID-19 vaccines J Med Virol Araf Y Akter F Tang YD Fatemi R Parvez MS Zheng C Hossain MG 1825 1832 94 2022 35023191
5 Coronavirus diseases and pregnancy: COVID-19,SARS, and MERS Przegl Epidemiol Fathi M Vakili K Deravi N 276 289 74 2020 33112124
6 Pandemic 2009 influenza A(H1N1) virus illness among pregnant women in the United States JAMA Siston AM Rasmussen SA Honein MA 1517 1525 303 2010 20407061
7 Update: characteristics of symptomatic women of reproductive age with laboratory-confirmed SARS-CoV-2 infection by pregnancy status - United States, January 22-October 3, 2020 MMWR Morb Mortal Wkly Rep Zambrano LD Ellington S Strid P 1641 1647 69 2020 33151921
8 Clinical manifestations, risk factors, and maternal and perinatal outcomes of coronavirus disease 2019 in pregnancy: living systematic review and meta-analysis BMJ Allotey J Stallings E Bonet M 0 370 2020
9 Pregnancy outcomes and maternal complications during the second wave of coronavirus disease 2019 (COVID-19) in India Obstet Gynecol Mahajan NN Pophalkar M Patil S Yewale B Chaaithanya IK Mahale SD Gajbhiye RK 660 662 138 2021 34233345
10 A comparative review of maternal and neonatal outcome among pregnant women with COVID-19 in first and second wave in a tertiary care centre of South Rajasthan Int J Reprod Contracept Obstet Gynecol Chaudhary D Chauhan M Gupta D Jat S 4471 4477 10 2021
11 Maternal and neonatal outcome of pregnant women with SARS-CoV-2 infection during the first and second wave of COVID-19 in a tertiary care institute in eastern India Cureus Singh V Choudhary A Datta MR Ray A 0 14 2022
12 Clinical presentation, pregnancy complications, and outcomes of pregnant women with COVID-19 during the Omicron-dominant third wave in Mumbai, India Int J Gynaecol Obstet Mahajan NN Kesarwani S Salunke C 968 973 159 2022 35861246
13 Advisory on purposive testing strategy for COVID-19 in India (version VII, dated 10th January 2022) 3 2024 2022 https://www.icmr.gov.in/pdf/covid/strategy/Advisory_COVID_Testing_10012022.pdf
14 Clinical management protocol for COVID-19 (in adults) 3 2024 2021 https://www.mohfw.gov.in/pdf/UpdatedDetailedClinicalManagementProtocolforCOVID19adultsdated24052021.pdf
15 Erratum: demographic comparison of the first, second and third waves of COVID-19 in a tertiary care hospital at Jaipur, India Lung India 98 40 2023 36695273
16 SARS-CoV-2 Omicron strain exhibits potent capabilities for immune evasion and viral entrance Signal Transduct Target Ther Zhang X Wu S Wu B 430 6 2021 34921135
17 Pregnancy outcomes in women with SARS-CoV-2 infection during the first and second waves of the COVID-19 pandemic in a tertiary care hospital in Ayodhya, Uttar Pradesh, India: a comparative study Cureus Ambedkar D Yadav Y Dubey P Kumar V Sharma R Mishra C 0 15 2023
18 Were pregnant women more affected by COVID-19 in the second wave of the pandemic? Lancet Kadiwar S Smith JJ Ledot S 1539 1540 397 2021 33864751
19 Acute liver injury in COVID- 19: prevalence and association with clinical outcomes in a large U.S. cohort Hepatology Phipps MM Barraza LH LaSota ED 807 817 72 2020 32473607
20 COVID-19 related liver injuries in pregnancy World J Clin Cases Sekulovski M Bogdanova-Petrova S Peshevska-Sekulovska M Velikova T Georgiev T 1918 1929 11 2023 36998958
21 Maternal and neonatal outcomes in pregnant women with SARS-CoV-2 infection complicated by hepatic dysfunction Cureus Choudhary A Singh V Bharadwaj M 0 14 2022
22 Increased cesarean section rates during the COVID-19 pandemic: looking for reasons through the Robson ten group classification system Rev Bras Ginecol Obstet Silva CE Guida JP Costa ML 0 6 45 2023
23 Timing and severity of COVID-19 during pregnancy and risk of preterm birth in the International Registry of Coronavirus Exposure in Pregnancy BMC Pregnancy Childbirth Smith LH Dollinger CY VanderWeele TJ Wyszynski DF Hernández-Díaz S 775 22 2022 36258186
24 Outcome of coronavirus spectrum infections (SARS, MERS, COVID-19) during pregnancy: a systematic review and meta-analysis Am J Obstet Gynecol MFM Di Mascio D Khalil A Saccone G 100107 2 2020 32292902
25 Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women: a retrospective review of medical records Lancet Chen H Guo J Wang C 809 815 395 2020 32151335
26 Study of the vertical transmission of COVID-19 by using the World Health Organisation protocol in a tertiary care hospital in eastern India Cureus Singh V Barik A Mishra M Diwakar K Choudhary A Mehta N 0 16 2024
